Skip to main content
Premium Trial:

Request an Annual Quote

UK Government Investigates COVID-19 Testing Firm

NEW YORK – The UK's Competition and Markets Authority said on Friday it has opened an investigation into a company following complaints that it did not provide COVID-19 test results in a timely manner or at all.

According to the CMA, Bradford, UK-based Expert Medicals has also failed to respond to customer complaints and refused to issue refunds to customers. The company is one of the largest providers of PCR-based travel tests for COVID-19, the CMA added, and has been the subject of "a high number of complaints" to consumer advocacy group Citizens Advice and to the CMA.

Expert Medicals has been removed from the UK's list of test providers who claim they meet minimum government standards for COVID-19 testing.

Additionally, the CMA has told another 19 testing firms to provide more pricing information or possibly face other action.

"The CMA is concerned that the 19 firms continue to falsely advertise tests at very low prices when they are either not available at that price or include hidden conditions, such as where the tests must be collected from," the CMA said in a statement.

The action follows a crackdown last month by the UK government on firms that provide PCR-based COVID-19 testing for possible price gouging and substandard services.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.